Work for Allogene Therapeutics, Inc.?

Claim Your Profile

Allogene Therapeutics, Inc. Logo Image

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. Banner Image

About Allogene Therapeutics, Inc.

201-500 Employees
Based in South San Francisco, California

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol